Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Adhera Therapeutics, Inc.atrx-20191231xexx322.htm
EX-32.1 - EXHIBIT 32.1 - Adhera Therapeutics, Inc.atrx-20191231xexx321.htm
EX-31.2 - EXHIBIT 31.2 - Adhera Therapeutics, Inc.atrx-20191231xexx312.htm
EX-31.1 - EXHIBIT 31.1 - Adhera Therapeutics, Inc.atrx-20191231xexx311.htm
EX-23.1 - EXHIBIT 23.1 - Adhera Therapeutics, Inc.atrx-20191231xex231.htm
EX-4.10 - EXHIBIT 4.10 - Adhera Therapeutics, Inc.atrx-20191231xexx410.htm
10-K - 10-K - Adhera Therapeutics, Inc.atrx-20191231x10k.htm
Exhibit 21.1

List of Subsidiaries
 
Name
 
State of Incorporation
 
Ownership
IthenaPharma Inc.
 
Delaware
 
100%
Cequent Pharmaceuticals, Inc.
 
Delaware
 
100%
MDRNA Research, Inc.
 
Delaware
 
100%
Atossa HealthCare, Inc.
 
Delaware
 
100%